nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Abstract
|
|
|
2012 |
2 |
4 |
p. 282- 1 p. |
artikel |
2 |
Acknowledgments
|
|
|
2012 |
2 |
4 |
p. 330- 1 p. |
artikel |
3 |
Biographic and Disclosure Information
|
|
|
2012 |
2 |
4 |
p. 324-329 6 p. |
artikel |
4 |
Chapter 1: Diagnosis and evaluation of anemia in CKD
|
|
|
2012 |
2 |
4 |
p. 288-291 4 p. |
artikel |
5 |
Chapter 4: Red cell transfusion to treat anemia in CKD
|
|
|
2012 |
2 |
4 |
p. 311-316 6 p. |
artikel |
6 |
Chapter 3: Use of ESAs and other agents* * Excluding iron which is discussed in Chapter 2. to treat anemia in CKD
|
|
|
2012 |
2 |
4 |
p. 299-310 12 p. |
artikel |
7 |
Chapter 2: Use of iron to treat anemia in CKD
|
|
|
2012 |
2 |
4 |
p. 292-298 7 p. |
artikel |
8 |
Foreword
|
|
|
2012 |
2 |
4 |
p. 280- 1 p. |
artikel |
9 |
Methods for guideline development
|
|
|
2012 |
2 |
4 |
p. 317-323 7 p. |
artikel |
10 |
Notice
|
|
|
2012 |
2 |
4 |
p. 279- 1 p. |
artikel |
11 |
References
|
|
|
2012 |
2 |
4 |
p. 331-335 5 p. |
artikel |
12 |
Summary of Recommendation Statements
|
|
|
2012 |
2 |
4 |
p. 283-287 5 p. |
artikel |
13 |
Work Group Membership
|
|
|
2012 |
2 |
4 |
p. 281- 1 p. |
artikel |